RT @DocCatenacci: @dralanburguete @KrishanJethwa 2b) RT+FLOT ME2: TOPGEAR Ph3 where art thou? -RadOnc led study -Initiated >10yrs ago -Peri…
@dralanburguete @KrishanJethwa 2b) RT+FLOT ME2: TOPGEAR Ph3 where art thou? -RadOnc led study -Initiated >10yrs ago -Periop ECX/FLOT amendment +/- preopRT -Type II Seiwert to distal stomach https://t.co/coajvlgVTB https://t.co/Hn8hiKCzVS https://t.co
@BodaHeggemann @JeremyPriceMD1 @KaitlynLapen @ARRO_org @ACROresident @RadoncTables Results from part 1 of the trial (phase 2 component) showed preop chemoradiation is safe without a significant increase in treatment toxicity or surgical morbidity. https:/
RT @CancerMgh: Article for conference today. It’s an older @AnnSurgOncol article but relevant to provide context for ongoing total neoadjuv…
Article for conference today. It’s an older @AnnSurgOncol article but relevant to provide context for ongoing total neoadjuvant discussions and trial designs in #esophageal and #stomach cancers. https://t.co/9QejCb6nIU
RT @GI_RadOnc: @sabinbmotwanimd The „ADVOCATES=TOPGEAR“ trial is currently recruiting... https://t.co/wKndlEySqu
@sabinbmotwanimd The „ADVOCATES=TOPGEAR“ trial is currently recruiting... https://t.co/wKndlEySqu
Feel free to speculate why @NRGonc didn't participate in the TOPGEAR phase III preop CRT gastric study. #radonc https://t.co/4ZK1vscfJ3